SynthesisBMC cardiovascular disorders2022

Safety and efficacy of interrupting dual antiplatelet therapy one month following percutaneous coronary intervention: a meta-analysis of randomized controlled trials.

Shane Parfrey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.